Integramed America, Inc. (INMD) Reports In-Line Q3 EPS, Sales Increase 15% Y/Y
Tweet
Share
E-mailGet Alerts INMD Hot Sheet
Join SI Premium – FREE
Integramed America, Inc. (NASDAQ: INMD) reported Q3 EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $69.4 million versus the consensus estimate of $68.51 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
